U01MH137067
Cooperative Agreement
Overview
Grant Description
Collaborative to understand impacts of early preventive interventions on suicide and overdose mortality using data harmonization methodology - Project summary
The goal of this application, submitted in response to RFA-MH-23-275, “Using secondary data analysis to determine whether preventive interventions implemented earlier in life reduce suicide risk,” is to conduct research that will integrate and harmonize existing large prevention trial datasets.
The included randomized clinical trials (RCT) were delivered before adulthood (prior to age 18) and did not explicitly target suicidal thoughts and behaviors (STB).
Each RCT consists of well-characterized participant-level prospective data with consent that allows for the harmonized data to be submitted to the NIMH Data Archive and allows for National Death Index searches.
This study will examine ‘cross-over effects’ (e.g., unanticipated beneficial effects) of the RCTs in reducing risk for later fatal and nonfatal STB, and related outcomes such as overdose, substance use disorders (SUD), opioid use disorders (OUD), accidents, and all-cause mortality.
This U01 proposal has obtained 29 existing prevention trial data sets with collaboration of the principal investigators and data custodians who have rights to the original data.
We will de-identify, aggregate, and harmonize the prevention trial datasets and utilize advanced computational/analytic strategies to examine whether intervening early reduces the risk for STB and related outcomes.
We will identify the most potent aspects by examining the various components of each intervention as well as the proximal and distal targets, format, setting, dose/duration, developmental timing, and quality of implementation.
Potential mediators and mechanisms of action (e.g., aspects of parenting, social factors, emotional and behavioral regulation) will also be studied and identified.
This effort will examine moderators of the effects of preventive interventions, including specific subpopulations (e.g., individuals from historically minoritized and socioeconomically disadvantaged backgrounds), and those individuals experiencing initial elevated levels of risk (e.g., systems-involved youth, youth who had experienced early trauma/adverse childhood events).
Data will be utilized from 29 trials involving 14 programs and 42,509 individuals.
With over 40,000 participants across all studies, harmonizing data will allow for more complex, multifactorial, multi-level analyses to explore intervention impacts on fatal and nonfatal STB and related outcomes as well as potential mediators, mechanisms, and moderators of impact.
The U01 team will oversee the preparation of a final harmonized prevention trial dataset to be deposited to the NIMH Data Archive (NDA) with data dictionaries and associated documentation from the original studies.
This project has the potential to inform the refinement and development of future preventive intervention strategies delivered early and scaled to address suicide and overdose in the US.
The goal of this application, submitted in response to RFA-MH-23-275, “Using secondary data analysis to determine whether preventive interventions implemented earlier in life reduce suicide risk,” is to conduct research that will integrate and harmonize existing large prevention trial datasets.
The included randomized clinical trials (RCT) were delivered before adulthood (prior to age 18) and did not explicitly target suicidal thoughts and behaviors (STB).
Each RCT consists of well-characterized participant-level prospective data with consent that allows for the harmonized data to be submitted to the NIMH Data Archive and allows for National Death Index searches.
This study will examine ‘cross-over effects’ (e.g., unanticipated beneficial effects) of the RCTs in reducing risk for later fatal and nonfatal STB, and related outcomes such as overdose, substance use disorders (SUD), opioid use disorders (OUD), accidents, and all-cause mortality.
This U01 proposal has obtained 29 existing prevention trial data sets with collaboration of the principal investigators and data custodians who have rights to the original data.
We will de-identify, aggregate, and harmonize the prevention trial datasets and utilize advanced computational/analytic strategies to examine whether intervening early reduces the risk for STB and related outcomes.
We will identify the most potent aspects by examining the various components of each intervention as well as the proximal and distal targets, format, setting, dose/duration, developmental timing, and quality of implementation.
Potential mediators and mechanisms of action (e.g., aspects of parenting, social factors, emotional and behavioral regulation) will also be studied and identified.
This effort will examine moderators of the effects of preventive interventions, including specific subpopulations (e.g., individuals from historically minoritized and socioeconomically disadvantaged backgrounds), and those individuals experiencing initial elevated levels of risk (e.g., systems-involved youth, youth who had experienced early trauma/adverse childhood events).
Data will be utilized from 29 trials involving 14 programs and 42,509 individuals.
With over 40,000 participants across all studies, harmonizing data will allow for more complex, multifactorial, multi-level analyses to explore intervention impacts on fatal and nonfatal STB and related outcomes as well as potential mediators, mechanisms, and moderators of impact.
The U01 team will oversee the preparation of a final harmonized prevention trial dataset to be deposited to the NIMH Data Archive (NDA) with data dictionaries and associated documentation from the original studies.
This project has the potential to inform the refinement and development of future preventive intervention strategies delivered early and scaled to address suicide and overdose in the US.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
Baltimore,
Maryland
212051900
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 179% from $2,834,044 to $7,912,274.
The Johns Hopkins University was awarded
Early Interventions Impact on Suicide & Overdose Mortality
Cooperative Agreement U01MH137067
worth $7,912,274
from the National Institute of Mental Health in August 2024 with work to be completed primarily in Baltimore Maryland United States.
The grant
has a duration of 3 years 9 months and
was awarded through assistance program 93.242 Mental Health Research Grants.
The Cooperative Agreement was awarded through grant opportunity Using Secondary Data Analysis to Determine Whether Preventive Interventions Implemented Earlier in Life Reduce Suicide Risk (U01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/26
Period of Performance
8/9/24
Start Date
5/31/28
End Date
Funding Split
$7.9M
Federal Obligation
$0.0
Non-Federal Obligation
$7.9M
Total Obligated
Activity Timeline
Subgrant Awards
Disclosed subgrants for U01MH137067
Transaction History
Modifications to U01MH137067
Additional Detail
Award ID FAIN
U01MH137067
SAI Number
U01MH137067-3337268493
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75N700 NIH National Institute of Mental Health
Funding Office
75N700 NIH National Institute of Mental Health
Awardee UEI
FTMTDMBR29C7
Awardee CAGE
5L406
Performance District
MD-07
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Modified: 8/20/26